Daniel C. Javitt serves as Executive at NRX Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Daniel C. Javitt has executed 13 insider transactions totaling $1.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 30, 2022 involved selling 8,441 shares valued at $12.7K.
Daniel C. Javitt currently holds 9,634,793 shares of NRX Pharmaceuticals, Inc. (NRXP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel C. Javitt has been a net seller of NRXP stock. They have purchased $0 and sold $1.4M worth of shares.
Daniel C. Javitt's most recent insider trade was on Nov 30, 2022, when they sold 8,441 shares at $1.50 per share.
Get notified when new Form 4 filings are submitted
| $1.50 |
| Discretionary |
| Nov 17, 2022 | NRXP | $34.7K | Sale | 33,018 | $1.05 | Discretionary |
| Nov 16, 2022 | NRXP | $136.4K | Sale | 133,719 | $1.02 | Discretionary |
| Nov 11, 2022 | NRXP | $49.7K | Sale | 49,200 | $1.01 | Discretionary |
| Jul 29, 2022 | NRXP | $791.9K | Sale | 784,063 | $1.01 | Discretionary |
| Jul 1, 2022 | NRXP | $0 | Gift | 2,000,000 | $N/A | Discretionary |
| Jun 7, 2022 | NRXP | $56.2K | Sale | 86,459 | $0.65 | Discretionary |
| Jun 6, 2022 | NRXP | $77.5K | Sale | 115,657 | $0.67 | Discretionary |
| Jun 3, 2022 | NRXP | $170.5K | Sale | 243,596 | $0.70 | Discretionary |
| Jul 16, 2021 | NRXP | $0 | Gift | 434,594 | $N/A | Discretionary |
| Jul 16, 2021 | NRXP | $0 | Gift | 434,594 | $N/A | Discretionary |
| May 24, 2021 | NRXP | $0 | Award | 13,971,864 | $N/A | Discretionary |